CEP
Chicago Equity Partners Portfolio holdings
AUM
$993M
1-Year Return
6.41%
This Quarter Return
+9.49%
1 Year Return
-6.41%
3 Year Return
+34.83%
5 Year Return
+90.27%
10 Year Return
–
AUM
$1.74B
AUM Growth
-$359M
(-17%)
Cap. Flow
-$508M
Cap. Flow
% of AUM
-29.14%
Top 10 Holdings %
Top 10 Hldgs %
11.26%
Holding
1,016
New
169
Increased
138
Reduced
507
Closed
163
Top Buys
| 1 |
Encore Capital Group
ECPG
|
$6.94M |
| 2 |
Intel
INTC
|
$6.62M |
| 3 |
Jabil
JBL
|
$6.14M |
| 4 |
Navient
NAVI
|
$6.06M |
| 5 |
Unum
UNM
|
$5.1M |
Top Sells
| 1 |
Microsoft
MSFT
|
$10.9M |
| 2 |
Visa
V
|
$9.71M |
| 3 |
PACW
PacWest Bancorp
PACW
|
$9.24M |
| 4 |
PayPal
PYPL
|
$8.9M |
| 5 |
Cisco
CSCO
|
$8.45M |
Sector Composition
| 1 | Technology | 17.07% |
| 2 | Financials | 16.14% |
| 3 | Healthcare | 12.72% |
| 4 | Consumer Discretionary | 11.68% |
| 5 | Industrials | 11.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Ziff Davis
ZD
$1.56B
| $2.61M | 0.15% |
31,987
+24,727
| +341% | +$2.02M |
|
202
Trinseo
TSE
$88.1M
| $2.6M | 0.15% |
+69,785
| New | +$2.6M |
|
203
Teradyne
TER
$19.1B
| $2.59M | 0.15% |
37,930
-2,715
| -7% | -$185K |
|
204
Medpace
MEDP
$13.7B
| $2.58M | 0.15% |
30,745
-19,770
| -39% | -$1.66M |
|
205
Zimmer Biomet
ZBH
$20.9B
| $2.56M | 0.15% |
17,644
-5,165
| -23% | -$751K |
|
206
Philip Morris
PM
$251B
| $2.55M | 0.15% |
29,980
-32,965
| -52% | -$2.8M |
|
207
Neurocrine Biosciences
NBIX
$14.3B
| $2.52M | 0.14% |
23,440
-9,050
| -28% | -$973K |
|
208
BlackLine
BL
$3.32B
| $2.52M | 0.14% |
48,830
-34,230
| -41% | -$1.77M |
|
209
BJs Wholesale Club
BJ
$12.8B
| $2.51M | 0.14% |
110,350
-67,315
| -38% | -$1.53M |
|
210
Baxter International
BAX
$12.5B
| $2.51M | 0.14% |
29,963
-43,924
| -59% | -$3.67M |
|
211
Great Lakes Dredge & Dock
GLDD
$798M
| $2.49M | 0.14% |
220,040
-32,605
| -13% | -$369K |
|
212
Booking.com
BKNG
$178B
| $2.49M | 0.14% |
1,212
-215
| -15% | -$442K |
|
213
International Seaways
INSW
$2.31B
| $2.48M | 0.14% |
+83,370
| New | +$2.48M |
|
214
Bristol-Myers Squibb
BMY
$96B
| $2.47M | 0.14% |
38,395
+22,370
| +140% | +$1.44M |
|
215
Boeing
BA
$174B
| $2.45M | 0.14% |
7,531
-4,005
| -35% | -$1.3M |
|
216
Eli Lilly
LLY
$652B
| $2.45M | 0.14% |
18,655
-2,035
| -10% | -$267K |
|
217
Starbucks
SBUX
$97.1B
| $2.45M | 0.14% |
27,820
-18,610
| -40% | -$1.64M |
|
218
RPM International
RPM
$16.2B
| $2.44M | 0.14% |
31,820
| – | – |
|
|
BBBY
219
DELISTED
Bed Bath & Beyond Inc
BBBY
| $2.43M | 0.14% |
140,620
+18,450
| +15% | +$319K |
|
220
Penumbra
PEN
$11B
| $2.42M | 0.14% |
14,740
-8,420
| -36% | -$1.38M |
|
221
Target
TGT
$42.3B
| $2.42M | 0.14% |
18,870
-6,450
| -25% | -$827K |
|
222
Arbor Realty Trust
ABR
$2.34B
| $2.41M | 0.14% |
167,935
-85,401
| -34% | -$1.23M |
|
|
INN
223
Summit Hotel Properties
INN
$614M
| $2.41M | 0.14% |
195,220
-13,230
| -6% | -$163K |
|
224
Avery Dennison
AVY
$13.1B
| $2.41M | 0.14% |
18,385
-425
| -2% | -$55.6K |
|
225
QuidelOrtho
QDEL
$1.95B
| $2.38M | 0.14% |
31,780
-28,585
| -47% | -$2.14M |
|